Evercore ISI Reiterates Outperform Rating on CVS Health (CVS)

Morgan Stanley Reiterates Overweight Rating on CVS Health (CVS)

October 2, 2024 6:56 AM EDT

Morgan Stanley analyst Erin Wright reiterated an Overweight rating and $65.00 price target on CVS Health (NYSE: CVS).

The analyst comments "Latest Hypothetical SOTP Suggests Upside, But Variables Remain: In light of a recent Reuters report (here) noting that the CVS Board may be considering potential options to break up CVS retail and insurance businesses, we detail our latest SOTP analysis, including key assumptions below. CVS declined to... More

Leerink Partners Reiterates Market Perform Rating on CVS Health (CVS)

October 1, 2024 6:28 AM EDT

Leerink Partners analyst Michael Cherny reiterated a Market Perform rating on CVS Health (NYSE: CVS).

The analyst comments "Bottom Line: Following our initial note highlighting the potential of CVS evaluating strategic alternatives including a break-up of the company (Initial CVS note; WSJ report) we wanted to include some quick views on the potential plusses and potential minuses of a breakup. This isn't meant to be comprehensive and is intentionally short form given the fluidity of the reported situation. But we thought it was important to highlight how this... More

CVS Health mulling options, including possible break-up - Reuters

October 1, 2024 4:47 AM EDT

Investing.com -- CVS Health (NYSE: CVS) is reportedly mulling options that would include the company breaking up its retail and insurance divisions, Reuters reported.

Citing people familiar with the matter, the news agency said CVS Health has been discussing several options, including the process of a split, with its financial advisors in recent weeks.

The plan has been a part of conversations among the firm's board of directors, although it has not yet decided... More

CVS explores options including potential break-up, sources say

September 30, 2024 7:02 PM EDT

By Anirban Sen

NEW YORK (Reuters) - CVS Health is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.

CVS has been discussing various options - including how such a split would work - with its financial advisers in recent weeks, the sources said, requesting anonymity as the discussions are confidential.

The plan to potentially split the company's pharmacy chain and the insurance business has... More

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.04%

September 30, 2024 5:05 PM EDT

Investing.com U.S. stocks were higher after the close on Monday, as gains in the Oil&Gas, Technology and Healthcare sectors led shares higher.

At the close in NYSE, the Dow Jones Industrial Average added 0.04% to hit a new all time high, while the S&P 500 index added 0.42%, and the NASDAQ Composite index climbed 0.36%.

The best performers of the session on the Dow Jones Industrial Average were Apple Inc (NASDAQ: AAPL), which rose 2.24% or 5.11 points to trade at 232.90 at the close. Meanwhile,... More

Glenview Capital to push CVS Health to make changes - Wall Street Journal

September 30, 2024 8:50 AM EDT

Investing.com -- A top hedge fund investor is planning to meet with top executives at CVS Health to propose ways for the ailing healthcare group to bolster its performance, according to The Wall Street Journal.

Citing people close to the matter, the paper said the meeting could be the start of the hedge fund, Glenview Capital Management, potentially taking an activist stance in its dealings with CVS Health.

Shares in CVS Health (NYSE:... More

Glenview Capital Prepares for Activist Push at CVS Health (CVS) - WSJ (earlier)

September 30, 2024 7:17 AM EDT

Glenview Capital Prepares for Activist Push at CVS Health (NYSE: CVS) - WSJ (earlier)

Larry Robbin's Glenview owns $700M of CVS shares.Glenview Capital plans to meet Monday with CVS to propose ways to improve operations.

... More